Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
OTC · USMJ · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
North American Cannabis Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow North American Cannabis Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
North American Cannabis Holdings, Inc. (USMJ), based in Farmers Branch, Texas, operates through its subsidiaries within the legal cannabis market across the United States. The company is actively involved in piloting various business opportunities with high growth potential within the cannabis sector. Beyond these strategic ventures, USMJ manages a specialized beverage establishment where consumers can learn about the benefits of cannabis and select from a variety of healthy, refreshing cannabis-infused drinks, including custom hemp-infused coffees, fresh cold-pressed juices, and smoothies. Additionally, it offers raw hemp seeds and a range of other hemp-derived food products. The company adopted its current name in June 2015, having previously been known as Algae International Group, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$275.20+$4.16 (+1.53%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.09% below the high.
$0.01$0.00 (0.0%)
ORHub, Inc.’s quoted price sits in the upper half of its reported 52-week range, 40.0% below the high.
$0.01$0.00 (0.0%)
DrazCanna, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (0.0%)
PaxMedica, Inc. Common Stock’s quoted price sits in the lower half of its reported 52-week range, 96.5% below the high.
$0.00$0.00 (0.0%)
Aeolus Pharmaceuticals, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Halo Collective Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
MPX International Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.